Molecular radiopharmaceuticals based on bioconjugates with peptides have major clinical impact in diagnosis and treatment of several types of diseases. Chelators are necessary modifications in clinical peptides. Our experience scientist at GenPep Pharmaceuticals can perform custom synthesis of metal chelator conjugates on the amino group at N-terminus or on ε-amino group of lysine at C-terminus. The commonly used metal chelating agents are DOTA, DIPA, NOTA, NODAGA and TETA








